Sensus jumps on prelim Q4 revenue beat

Sensus Healthcare

23/01/2024 14:17

** Shares of medical device maker Sensus Healthcare 
 SRTS.O  rise 20.3% to $3.20 premarket
    ** Co reports prelim Q4 revenue of more than $12 mln vs
analysts' average expectation of $7.5 mln - LSEG data
    ** Says co's business in Q4 was helped by an increase in the
shipment of superficial radiotherapy systems used in the
treatment of non-melanoma skin cancer
    ** SRTS plans to report its Q4 2023 results on Feb. 8
    ** As of the last close, stock down 71.1% in the last 12
months

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))